Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Clinical trial NCT00595088 · COMPLETED
Trial details
- NCT number
- NCT00595088
- Sponsor
- Anchiano Therapeutics Israel Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2013-01-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.